Answers are grounded in this paper and cite their sources.
Background and Objectives: AI-assisted retinal imaging is increasingly proposed to expand diabetic retinopathy (DR) screening capacity, but most validation studies use reading-center standards, exclude prediabetes, and assess macular edema against photographic surrogates rather than optical coherence tomography (OCT). We compared an AI-assisted retinal screening system with routine ophthalmological examination in an unselected internal medicine screening population. Materials and Methods: In this prospective, cross-sectional diagnostic accuracy study, consecutive adults with prediabetes or diabetes underwent AI-assisted retinal imaging (index test) followed by masked ophthalmological examination (reference standard), with OCT as the reference for macular edema. Analyses were performed at the eye level (n = 714) and patient level (n = 357) using Wilson score 95% confidence intervals and Cohen kappa (κ) for agreement. Results: Among 357 patients (714 eyes; 83.8% diabetes, 16.2% prediabetes), DR prevalence by ophthalmological examination was 15.0% (eyes) and 17.9% (patients), versus 24.4% and 33.1% by AI (McNemar p < 0.001). Eye-level and patient-level sensitivity and specificity were 70.1% and 83.7% and 75.0% and 76.1%, respectively. Negative predictive value was high (93–94%) but positive predictive value was low (41–43%); agreement was moderate at the eye level and fair at the patient level (κ = 0.428 and 0.384, respectively). False-positive AI calls were associated with higher HbA1c and albuminuria (adjusted odds ratio for log-transformed ACR 1.23, p = 0.040); false negatives had milder disease. In prediabetes, DR prevalence was 1.7% and agreement was absent (κ = −0.03). AI sensitivity for OCT-defined macular edema was 45.5% (κ = 0.197), with no significant central macular thickness difference by AI status. Conclusions: The AI system showed high negative predictive value but systematically over-called DR, with only fair-to-moderate agreement and performance below accepted screening benchmarks, particularly in prediabetes and for macular edema. These findings support its use as a rule-out triage adjunct with ophthalmological confirmation of positive results, rather than an autonomous substitute, and argue for local recalibration before deployment.
No takes yet. Share an insight, caveat, or question.
Arıcı et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: